Showing results (51-60 of 54) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
The Lancet. Oncology|September 3, 2019
Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trialMansoor Raza Mirza, Elisabeth Åvall Lundqvist, Michael J Birrer, et al.Translational Oncology|March 20, 2026
Exploring survival-associated transcriptomic subtypes in ovarian cancer using RNAseq from FFPE tissues in a clinical trial cohortMaj K Kjeldsen, Frederik Otzen Bagger, Henrik Roed, et al.Cancer Research Communications|November 26, 2024
Beyond HRD Status: Unraveling Genetic Variants Impacting PARP Inhibitor Sensitivity in Advanced Ovarian CancerMaj K Kjeldsen, Morten Jørgensen, Dina Sofie B Grønseth, et al.Journal of Comparative Effectiveness Research|December 6, 2024
Use of individualized starting dose and niraparib hematologic adverse event management costs in ovarian cancerWhitney S Graybill, Ignace Vergote, Bhavana Pothuri, et al.Pageof 6